Comparon IVS: Financial statements 2017
CVR: 37794414
Comparon IVS (CVR 37794414) has filed annual accounts for 2017. In 2017, the company reported a net result of DKK -4,875. Equity amounted to DKK 126. The solvency ratio was 100%.
- Profit/Loss
- -4,875 kr.
- Equity
- 126 kr.
- Total Assets
- 126 kr.
Find more companies like Comparon IVS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2017
Comparon IVS has published its interim report for the period June 13, 2016 – December 31, 2016.
As of October 3, 2017, Andreas Casper Christensen Linde has joined the board of directors of Comparon IVS.
As of October 3, 2017, Stefan Vinding Olesen has joined the board of directors of Comparon IVS.
As of October 3, 2017, Andreas Casper Christensen Linde is registered as director of Comparon IVS.
As of October 3, 2017, Stefan Vinding Olesen is registered as director of Comparon IVS.
As of October 3, 2017, Henrik Løvig Jensen is registered as chairman of Comparon IVS.
As of August 31, 2017, Andreas Casper Christensen Linde has left the board of directors of Comparon IVS.
As of August 31, 2017, Stefan Vinding Olesen has left the board of directors of Comparon IVS.
As of August 31, 2017, Anders Hyldborg has left the board of directors of Comparon IVS.
As of August 31, 2017, Andreas Casper Christensen Linde has stepped down as director of Comparon IVS.
About Comparon IVS
Comparon IVS was a Danish company of the type Iværksætterselskab based in Aarhus N, founded in 2016 and dissolved in 2018. The company was registered under the industry Webportaler. In 2017, the company reported a net result of DKK -4,875. Equity amounted to DKK 126.
